We concomitantly applied both clinical rating scales as well as neurocognitive testing procedures in a virtual reality setting in order to determine whether DAT density was correlated to measures of ADHD symptoms and cognitive performance. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.